Teng, J.; Fischler, B.; Bohlin, K.; Reilly, M.; Tiblad, E.
Comment on Drozdowska-Szymczak et al. Incidence and Risk Factors of Cholestasis in Newborns with Hemolytic Disease—A Case-Control Study. J. Clin. Med. 2024, 13, 3190. J. Clin. Med. 2024, 13, 7047.
https://doi.org/10.3390/jcm13237047
AMA Style
Teng J, Fischler B, Bohlin K, Reilly M, Tiblad E.
Comment on Drozdowska-Szymczak et al. Incidence and Risk Factors of Cholestasis in Newborns with Hemolytic Disease—A Case-Control Study. J. Clin. Med. 2024, 13, 3190. Journal of Clinical Medicine. 2024; 13(23):7047.
https://doi.org/10.3390/jcm13237047
Chicago/Turabian Style
Teng, Jonas, Björn Fischler, Kajsa Bohlin, Marie Reilly, and Eleonor Tiblad.
2024. "Comment on Drozdowska-Szymczak et al. Incidence and Risk Factors of Cholestasis in Newborns with Hemolytic Disease—A Case-Control Study. J. Clin. Med. 2024, 13, 3190" Journal of Clinical Medicine 13, no. 23: 7047.
https://doi.org/10.3390/jcm13237047
APA Style
Teng, J., Fischler, B., Bohlin, K., Reilly, M., & Tiblad, E.
(2024). Comment on Drozdowska-Szymczak et al. Incidence and Risk Factors of Cholestasis in Newborns with Hemolytic Disease—A Case-Control Study. J. Clin. Med. 2024, 13, 3190. Journal of Clinical Medicine, 13(23), 7047.
https://doi.org/10.3390/jcm13237047
